This site is intended for healthcare professionals
  • Home
  • /
  • Journals
  • /
  • HIV infection
  • /
  • Long-term data on the efficacy and tolerability of...
Journal

Long-term data on the efficacy and tolerability of lamivudine plus dolutegravir as a switch strategy in a multi-centre cohort of HIV-1-infected, virologically suppressed patients

Read time: 1 mins
Published:30th Nov 2019
Author: Baldin G, Ciccullo A, Rusconi S, Capetti A, Sterrantino G, Colafigli M et al.
Availability: Pay for access, or by subscription
Ref.:Int J Antimicrob Agents. 2019 Dec;54(6):728-734.
DOI:10.1016/j.ijantimicag.2019.09.002.
Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest